Personal tools

Coexpression cluster:C976: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C976_anaplastic_small_retinoblastoma_gastrointestinal_merkel_neuroblastoma_carcinoid |id=C976 }}")
 
No edit summary
Line 2: Line 2:
|full_id=C976_anaplastic_small_retinoblastoma_gastrointestinal_merkel_neuroblastoma_carcinoid
|full_id=C976_anaplastic_small_retinoblastoma_gastrointestinal_merkel_neuroblastoma_carcinoid
|id=C976
|id=C976
|ontology_enrichment_celltype=CL:0002319!8.00e-07!25
|ontology_enrichment_disease=DOID:3095!9.04e-08!22;DOID:2994!9.04e-08!22
|ontology_enrichment_uberon=UBERON:0000073!3.45e-18!94;UBERON:0001016!3.45e-18!94;UBERON:0005743!1.16e-16!86;UBERON:0001017!3.10e-15!82;UBERON:0000924!5.67e-15!173;UBERON:0006601!5.67e-15!173;UBERON:0004121!1.02e-13!169;UBERON:0002346!3.96e-13!90;UBERON:0000955!8.06e-13!69;UBERON:0006238!8.06e-13!69;UBERON:0000153!1.05e-12!129;UBERON:0007811!1.05e-12!129;UBERON:0003075!9.34e-12!86;UBERON:0007284!9.34e-12!86;UBERON:0000033!4.27e-11!123;UBERON:0002616!1.08e-10!59;UBERON:0001049!2.81e-10!57;UBERON:0005068!2.81e-10!57;UBERON:0006241!2.81e-10!57;UBERON:0007135!2.81e-10!57;UBERON:0003056!1.12e-09!61;UBERON:0002780!1.03e-08!41;UBERON:0001890!1.03e-08!41;UBERON:0006240!1.03e-08!41;UBERON:0003080!3.11e-08!42;UBERON:0007023!5.02e-07!115;UBERON:0001893!8.44e-07!34
}}
}}

Revision as of 15:00, 21 May 2012


Full id: C976_anaplastic_small_retinoblastoma_gastrointestinal_merkel_neuroblastoma_carcinoid



Phase1 CAGE Peaks

Hg19::chr10:21813558..21813582,+p@chr10:21813558..21813582
+
Hg19::chr17:55601662..55601678,+p@chr17:55601662..55601678
+
Hg19::chr17:55601680..55601693,+p@chr17:55601680..55601693
+
Hg19::chr6:20686649..20686670,+p@chr6:20686649..20686670
+
Hg19::chr6:20686715..20686738,+p@chr6:20686715..20686738
+
Hg19::chr6:20689192..20689203,+p@chr6:20689192..20689203
+
Hg19::chr6:20689228..20689240,+p@chr6:20689228..20689240
+
Hg19::chr6:20716926..20716929,+p@chr6:20716926..20716929
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen
neural cell8.00e-0725
Uber Anatomy
Ontology termp-valuen
regional part of nervous system3.45e-1894
nervous system3.45e-1894
central nervous system3.10e-1582
ectoderm5.67e-15173
presumptive ectoderm5.67e-15173
ectoderm-derived structure1.02e-13169
neurectoderm3.96e-1390
brain8.06e-1369
future brain8.06e-1369
anterior region of body1.05e-12129
craniocervical region1.05e-12129
neural plate9.34e-1286
presumptive neural plate9.34e-1286
head4.27e-11123
regional part of brain1.08e-1059
neural tube2.81e-1057
neural rod2.81e-1057
future spinal cord2.81e-1057
neural keel2.81e-1057
pre-chordal neural plate1.12e-0961
regional part of forebrain1.03e-0841
forebrain1.03e-0841
future forebrain1.03e-0841
anterior neural tube3.11e-0842
adult organism5.02e-07115
telencephalon8.44e-0734
Disease
Ontology termp-valuen
germ cell and embryonal cancer9.04e-0822
germ cell cancer9.04e-0822


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.